HCA Healthcare, Inc. (HCA)
What changed in recent filings
- Institutions — 2 new · 3 added · 1 reduced13F · as of end of 2026 Q2
What changed in recent SEC filings — factual, not a buy/sell recommendation.
HCA Healthcare, Inc. recent earnings releases
Based on SEC filings. The release date is the day the earnings filing (8-K) was accepted; for quarters where that filing was not found, the periodic report filing date is shown.
- 26Q2Released Jul 14, 2026Revenue +8.7% YoY · EPS $7.62Released before the open: Jul 13 close → Jul 14 close, the stock moved -6.9% · over the same window, market +0.4% · sector -1.4%
- 26Q1Released Apr 24, 2026Revenue +4.3% YoY · EPS $7.15Released before the open: Apr 23 close → Apr 24 close, the stock moved -8.8% · over the same window, market +0.8% · sector -0.9%
- 25Q4Released Jan 27, 2026Revenue +6.7% YoY · EPS $8.10Released before the open: Jan 26 close → Jan 27 close, the stock moved +7.1% · over the same window, market +0.4% · sector -0.2%
- 25Q3Released Oct 24, 2025Revenue +9.6% YoY · EPS $6.96Released before the open: Oct 23 close → Oct 24 close, the stock moved +1.6% · over the same window, market +0.8% · sector -0.1%
The next earnings release is estimated around Oct 23, 2026 (calculated from how long this company has taken between quarter end and filing; it is not a date announced by the company).
Institutions holding HCA Healthcare, Inc.
How many of the institutions we track reported holding this stock, quarter by quarter.
2019 Q1: 7 → 2026 Q2: 8 institutions
Counts the 52 institutions we track that reported holding this stock — their full reported holdings, not just the largest positions. Not the total number of institutional holders in the US. Figures are as of quarter-end and disclosed up to 45 days later. Descriptive only — not investment advice.
Which institutions hold HCA Healthcare, Inc.
Institutions we track that reported holding this stock in their most recent 13F.
- National Pension Service (Korea)0.15% of portfolio · held as of 2019 Q1 or earlier
- Harris Associates (Oakmark)0.08% of portfolio · held as of 2019 Q1 or earlier
- Bridgewater Associates0.33% of portfolio · since 2020 Q1
- Capital World Investors0.09% of portfolio · since 2023 Q3
- Pzena Investment Management0.11% of portfolio · since 2025 Q1
- Caisse de depot (Quebec)0.04% of portfolio · since 2025 Q3
- Temasek Holdings (Singapore)New this quarter0.01% of portfolio · since 2026 Q2
- BlackstoneNew this quarterunder 0.01% of portfolio · since 2026 Q2
Based on 13F filings — quarter-end holdings, disclosed up to 45 days later. Holding a stock is a fact we report, not a recommendation to buy or sell.
Q2 2026 13F recap — stocks several institutions bought and sold together →Company overview
The largest US private hospital chain, operating over 180 hospitals and more than 2,000 outpatient facilities.
What is the Biotech & Health sector?
Pharma, biotech, and medical devices. Driven by trial-result events.
HCA Healthcare, Inc. is classified under the Biotech & Health sector. See peers below.
HCA Healthcare, Inc. key financials
Based on SEC filings · as of Jun 30, 2026
Tap a metric name to see its meaning in the glossary.
HCA Healthcare, Inc. vs Biotech & Health sector benchmark
Median of 38 representative sector stocks · SEC filings · factual comparison (not advice)
A simple comparison to the sector benchmark. Higher or lower doesn’t mean good/bad or buy/sell.
ETFs holding HCA Healthcare, Inc.
Per SEC N-PORT · 2026-06-30 · by weight · factual
HCA on Stocklore
- Revenue by segment — segment weights verified from SEC filings, YoY changes, growth drivers and concentration
- Financials & earnings quality — 6 metrics (FCF conversion, ROIC, net debt, etc.) to gauge profit quality
- 13F institutional holdings — holdings and weight changes of major institutions (45-day delay)
- Sector-relative metrics — Valuation and growth compared with the Biotech & Health average
Peers · Biotech & Health
HCA FAQ
What is HCA Healthcare, Inc. (HCA)?
The largest US private hospital chain, operating over 180 hospitals and more than 2,000 outpatient facilities.
What sector is HCA Healthcare, Inc. in?
HCA Healthcare, Inc. is classified under Biotech & Health. Pharma, biotech, and medical devices. Driven by trial-result events.
What are HCA Healthcare, Inc.'s key financials?
As of Jun 30, 2026 in SEC filings: Revenue growth (YoY) 7.3%, Net margin 8.8%. Definitions and interpretation are available on Stocklore.
Where can I analyze HCA Healthcare, Inc. (HCA) stock?
On Stocklore you can see HCA's financials & earnings quality, 13F institutional holdings, and sector-relative metrics in one place. This page is for information and tools — not a buy/sell recommendation.
Data sources: SEC EDGAR (financials & filings), 13F (institutional holdings, as of quarter-end), market data. This page is for information and analysis tools — it does not recommend buying or selling any security. Investment decisions and responsibility are your own.